The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1)

FOREWORD  NEUROENDOCRINE UPDATE AND METABOLIC THERAPY

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):1-2

Diagnosis and therapy of neuroendocrine tumours

Bombardieri E., Virgolini I.

PDF

REVIEWS  NEUROENDOCRINE UPDATE AND METABOLIC THERAPY

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):3-15

Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticals

Bombardieri E., Coliva A., Maccauro M., Seregni E., Orunesu E., Chiti A., Lucignani G.

Abstract PDF

REVIEWS  NEUROENDOCRINE UPDATE AND METABOLIC THERAPY

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):16-23

Imaging of NETs with PET radiopharmaceuticals

Ambrosini V., Tomassetti P., Franchi R., Fanti S.

Abstract PDF

REVIEWS  NEUROENDOCRINE UPDATE AND METABOLIC THERAPY

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):24-36

The non tumour uptake of 111In-octreotide creates new clinical indications in benign diseases, but also in oncology

Cascini G. L., Cuccurullo V., Mansi L.

Abstract PDF

REVIEWS  NEUROENDOCRINE UPDATE AND METABOLIC THERAPY

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):37-51

Dosimetry for treatment with radiolabelled somatostatin analogues. A review

Cremonesi M., Botta F., Di Dia A., Ferrari M., Bodei L., De Cicco C., Rossi A., Bartolomei M., Mei R., Severi S., Salvatori M., Pedroli G., Paganelli G.

Abstract PDF

ORIGINAL ARTICLES  NEUROENDOCRINE UPDATE AND METABOLIC THERAPY

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):52-60

Preliminary experience with 68Ga-DOTA-lanreotide positron emission tomography

Traub-Weidinger T., Von Guggenberg E., Dobrozemsky G., Kendler D., Eisterer W., Bale R., Putzer D., Gabriel M., Virgolini I.

Abstract PDF

ORIGINAL ARTICLES  NEUROENDOCRINE UPDATE AND METABOLIC THERAPY

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):61-7

Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions

Prasad V., Baum R. P.

Abstract PDF

ORIGINAL ARTICLES  NEUROENDOCRINE UPDATE AND METABOLIC THERAPY

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):68-75

Comparison of 68Ga-DOTA-Tyr3-octreotide and 18F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients

Putzer D., Gabriel M., Kendler D., Henninger B., Knoflach M., Kroiss A., Vonguggenberg E., Warwitz B., Virgolini I. J.

Abstract PDF

ORIGINAL ARTICLES  NEUROENDOCRINE UPDATE AND METABOLIC THERAPY

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):76-83

Comparison of positron emission tomography with [18F]FDG and [68Ga]DOTATOC in recurrent differentiated thyroid cancer: preliminary data

Middendorp M., Selkinski I., Happel C., Kranert W. T., Grünwald F.

Abstract PDF

ORIGINAL ARTICLES  NEUROENDOCRINE UPDATE AND METABOLIC THERAPY

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):84-91

Treatment with tandem [90Y]DOTA-TATE an [177Lu] DOTA-TATE of neuroendocrine tumors refractory to conventional therapy: preliminary results

Seregni E., Maccauro M., Coliva A., Castellani M. R., Bajetta E., Aliberti G., Vellani C., Chiesa C., Martinetti A., Bogni A., Bombardieri E.

Abstract PDF

ORIGINAL ARTICLES  NEUROENDOCRINE UPDATE AND METABOLIC THERAPY

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):92-9

Individualized peptide-related-radionuclide-therapy concept using different radiolabelled somatostatin analogs in advanced cancer patients

Gabriel M., Andergassen U., Putzer D., Kroiss A., Waitz D., Von Guggenberg E., Kendler D., Virgolini I. J.

Abstract PDF

ORIGINAL ARTICLES  NEUROENDOCRINE UPDATE AND METABOLIC THERAPY

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):100-13

131I-MIBG treatment of pheochromocytoma: low versus intermediate activity regimens of therapy

Castellani M. R., Seghezzi S., Chiesa C., Aliberti G. L., Maccauro M., Seregni E., Orunesu E., Luksch R., Bombardieri E.

Abstract PDF